Abstract
Infection preventive practice of using disinfectants against SARS-CoV-2 has become the new normal due to the COVID-19 pandemic. Although disinfectants may not be applied directly to the human body, it remains at high risk of exposure including close skin contact on disinfected surfaces or during handling. This dermal contact, on a regular basis, can induce hazardous skin reactions like irritation, inflammation, and burning in severe conditions. Disinfectants are germicide chemicals that can penetrate the skin and create skin reactions that are usually regarded as irritant and allergic contact dermatitis. More importantly, disinfectants can react with skin components (proteins and lipids) to facilitate their skin penetration and disrupt the skin barrier function. Whereas the antimicrobial actions of disinfectants are well understood, much less is known regarding their dermatologic reactions, including but not limited to irritation and hypersensitivity. We reviewed the skin reactions created by those disinfectants against SARS-CoV-2 approved by the European Chemical Agency and the US Environmental Protection Agency.
Introduction
The emergence of a novel coronavirus (SARS-CoV-2) at the end of 2019 was declared as a global pandemic by the World Health Organization (WHO) on March 11, 2020.1 The alarming situation has triggered the practice of preventive actions that include the use of various disinfectants to sanitize the environment and to reduce the spread of infections. Owing to unawareness and inadequate experience in handling disinfectants among the public, this may cause an inappropriate use of disinfectants, which can create untoward events. Our skin is, thus, at risk of exposure to disinfectants, especially during handling, storage, and application. Even though direct contact with disinfectants may not be often established, the risk of skin contact to the chemical residuals on disinfected surfaces remains high, especially when disinfectant use has become a routine practice.
Disinfectants are small and moderately lipophilic molecules (molecular weight <500 Da and log P ~1 to 4), which can penetrate the skin to induce a direct skin reaction. Skin reactions to various disinfectants can be wide, ranging from inflammation, lichenification, to discoloration, and even necrosis. Disinfectants are germicidal by definition and can react with epidermal keratin filaments and lipids, similar to reactions created by many antimicrobials to the lipid membrane and protein structure of microorganisms. These actions can facilitate skin penetration of chemicals into the deeper skin layers to aggravate any adverse reactions.
Most disinfectants can be regarded as potential skin irritants and/or sensitizers (allergens), including those indicated for human hygiene, such as alcohols and peroxygen compounds.2 In response to external stimuli such as disinfectants, the skin immune system can react by secreting a range of proinflammatory mediators, including cytokines and chemokines, especially from keratinocytes, T cells, and dermal fibroblasts.[3], [4] They can create irritant (ICD) or allergic contact dermatitis (ACD).5 ICD is a nonspecific inflammatory response triggered by innate immune system due to toxic effects on the skin cells.5 While ACD is considered a delayed hypersensitivity response, where skin inflammation is mediated by antigen-specific T cells (adaptive immunity). The inflammation is not directly caused by the chemicals but rather the response of T cells to the haptenized protein.5
We have provided a comprehensive summary of dermatologic reactions due to the exposure of disinfectants. The data on percutaneous penetration and interactions with skin components in facilitating skin penetration are also highlighted. We have included only the disinfectants commonly found in consumer products from the lists of disinfectants approved by (1) the European Chemical Agency6 and (2) the US Environmental Protection Agency7 for use against SARS-CoV-2, where these disinfectants have demonstrated efficacy against a harder-to-kill virus or another type of human coronavirus similar to SARS-CoV-2.
Classification of disinfectants
Table 1 shows the list of disinfectants commonly found in consumer products based on the various chemical classes and their examples and have included adverse reactions associated with the use of disinfectants and their skin penetration ability in Table 2, Table 3 .
Table 1.
Classification of disinfectants and related examples
Classification | Examples |
---|---|
Alcohols | Ethanol, isopropanol |
Aldehydes | Glutaraldehyde |
Bases |
Oxides/hydroxides Calcium dihydroxide, calcium hydroxide, calcium magnesium oxide, calcium magnesium tetrahydroxide, calcium oxide |
Carbonates Sodium carbonate, sodium carbonate peroxyhydrate, ammonium bicarbonate, ammonium carbonate | |
Biguanides | Polyhexamethylene biguanide hydrochloride (polyhexanide) |
Chlorine and chlorine compounds | Chlorine dioxide, hydrochloric acid, hypochlorous acid, sodium chlorite, sodium hypochlorite, sodium dichloro-S-triazinetrione (sodium dichloroisocyanurate) |
Glycols | Triethylene glycol, 1,2-hexanediol |
Iodophors | Polyvinylpyrrolidone iodine |
Metal ions | Silver ions, copper ions (copper sulfate pentahydrate) |
Organic acids |
α-Hydroxy acids Citric acid, glycolic acid, lactic acid |
Fatty acids Caprylic acid (octanoic acid), pelargonic acid (nonanoic acid) | |
Peroxygen compounds | Hydrogen peroxide, peroxyacetic acid (peracetic acid), potassium peroxymonosulfate |
Phenolic compounds | Ortho-phenylphenol, ortho-benzyl-para-chlorophenol, thymol, chlorocresol |
Surfactants |
Anionic surfactants Dodecylbenzenesulfonic acid |
Cationic surfactants/quaternary ammonium compounds Old generation: benzalkonium chloride (alkyl dimethyl benzyl ammonium chloride), benzethonium chloride New generation: dialkyl dimethyl ammonium halide/carbonate (didecyl dimethyl ammonium chloride/carbonate, octyl decyl dimethyl ammonium chloride, dioctyl dimethyl ammonium bromide, didecyl dimethyl ammonium bicarbonate), dimethyl ethylbenzyl ammonium chloride | |
Thiazoles | Methylchloroisothiazolinone, methylisothiazolinone |
Table 2.
Skin irritation, sensitization, and significant skin manifestations of disinfectants
Classification | Examples | Skin irritation | Skin sensitization | Skin manifestations | Effect on skin components |
---|---|---|---|---|---|
Alcohols | Ethanol | Yes8,12,14 | No[18], [19], [20] | Dryness, itchiness, burning (at high concentrations) | • Stratum corneum (SC) lipid solubilization, fluidization, and extraction[111], [112], [113], [114], [115] • SC protein denaturation112,116 |
Isopropanol | Yes8,12,14 | No[18], [19], [20] | |||
Aldehydes | Glutaraldehyde | Yes24,25 | Yes24,25 | Yellow-brown discoloration | • Crosslinking with protein (discoloration)27 |
Biguanides | Polyhexamethylene biguanide hydrochloride (polyhexanide) | No34 | Yes29,34 | Edema, redness, flaking with papules | n.a. |
Chlorine and chlorine compounds | Sodium hypochlorite | Yes38,39 | No40 | Burning sensation, pain, redness, edema, blisters, tissue necrosis | • SC protein and lipid oxidation[117], [118], [119] |
Glycols | Triethylene glycol | No120 | No120 | n.a. | n.a. |
1,2-Hexanediol | No121,122 | No122 | n.a. | • SC lipid fluidization and disordering[121], [122], [123] | |
Iodophors | Polyvinylpyrrolidone iodine | No[44], [45], [46], [47], [48], [49] | No124 | Burns with blisters and tissue necrosis (associated with wounds) | n.a. |
Metal ions | Silver ions | No58 | No58 | Brown-black discoloration | • Photoreduction on keratin protein (discoloration)59,60 |
α-Hydroxy acids | Citric acid | No61,125 | No61,125 | Peeling, burning, skin thickening, reversible photosensitivity, contact urticaria, reduced melanin deposition | • Disruption of tight junction and adhesion of keratinocytes126 • Inhibition of tyrosinase activities of melanocytes74 |
Glycolic acid | Yes61,125 | No61,125 | |||
Lactic acid | Yes61,125 | No61,125 | |||
Fatty acids | Caprylic acid (octanoic acid) | Yes[127], [128], [129] | No[127], [128], [129] | n.a. | n.a. |
Pelargonic acid (nonanoic acid) | Yes[127], [128], [129] | No[127], [128], [129] | Skin thickening | • Epidermal cell apoptosis, reduction of keratinocyte proliferation, and Langerhans cells127,129,130 • SC lipid disordering131 • Surfactant action on keratin protein and cell membranes127 |
|
Peroxygen compounds | Hydrogen peroxide | Yes75,[78], [79], [80] | No75,[78], [79], [80] | Blanching, vacuolar eruption, erythema, edema, peeling, burns (at high concentrations) | • Hemoglobin oxidation, oxygen-induced vasoconstriction76,132 • SC protein and lipid oxidation, lipid solubilization |
Peroxyacetic acid (peracetic acid) | Yes82 | No82 | Burning sensation, itchiness | n.a. | |
Phenolic compounds | Ortho-phenylphenol | Yes133 | No133 | Leucoderma | • Inhibition of tyrosinase activities of melanocytes134 |
Thymol | No135 | No135 | n.a. | • SC lipid fluidization136,137 • SC protein denaturation and lipid plasticization138 |
|
Chlorocresol | Yes139,140 | Noa,139,140 | Urticaria141,142 | Protein denaturation and lipid plasticization138 | |
Anionic surfactants | Dodecylbenzenesulfonic acid | Yes143 | No143 | Roughness, erythema | • SC protein denaturation and lipid solubilization144,145 |
Cationic surfactants | Benzalkonium chloride (alkyl dimethyl benzyl ammonium chloride) | Yes146,147 | Noa,146,147 | Inflammation | • SC lipid solubilization (cholesterols)97,148 • SC protein denaturation149 |
Benzethonium chloride | Yes150 | Noa,150 | |||
Didecyl dimethyl ammonium chloride | Yes[101], [102], [103], [104], [105] | Yes[101], [102], [103], [104], [105] | Urticaria, swelling, erythema, itchiness | • SC lipid solubilization (cholesterols)151 |
n.a., not available/unknown.
Potential due to increased cases.
Table 3.
Molecular weight, log P, and skin penetration of disinfectants
Classification | Examples | Molecular weight (Da) | Log Pa | Skin penetration |
---|---|---|---|---|
Alcohols | Ethanol | 46.1 | −0.16 | Yes (low)9,10 |
Isopropanol | 60.1 | 0.25 | ||
Aldehydes | Glutaraldehyde | 100.1 | −0.27 | Yes (low)22,23 |
Biguanides | Polyhexamethylene biguanide hydrochloride (polyhexanide) | Variable (average: 1415.0) | −2.3934 | Yes (low)28 |
Chlorine and chlorine compounds | Sodium hypochlorite | 74.4 | 0.32 | Yes (very low)38 |
Chlorine dioxide | 67.5 | 0.26 | No42 | |
Glycols | Triethylene glycol | 150.2 | −1.30 | No152 |
1,2-Hexanediol | 118.2 | 0.62 | ||
Iodophors | Polyvinylpyrrolidone iodine | 365.0 | 1.36 (iodine) | Yes43 |
Metal ions | Silver ions | 107.9 | −0.73 | Yes (low)56 |
α-Hydroxy acids | Citric acid | 192.1 | −1.32 | Yes[61], [62], [63], [64] |
Glycolic acid | 76.1 | −1.04 | ||
Lactic acid | 90.1 | −0.47 | ||
Fatty acids | Caprylic acid (octanoic acid) | 144.2 | 2.70 | Yes128 |
Pelargonic acid (nonanoic acid) | 158.2 | 3.14 | Yes128 | |
Peroxygen compounds | Hydrogen peroxide | 34.0 | −0.45 | n.a. |
Peroxyacetic acid (peracetic acid) | 76.1 | −0.30 | n.a. | |
Phenolic compounds | Ortho-phenylphenol | 170.2 | 3.32 | Yes84,85,[153], [154], [155], [156] |
Thymol | 150.2 | 3.43 | Yes (very low)138 | |
Chlorocresol | 142.6 | 2.79 | Yes (very low)138 | |
Anionic surfactants | Dodecylbenzenesulfonic acid | 326.5 | 6.56 | No92 |
Cationic surfactants | Benzalkonium chloride (alkyl dimethyl benzyl ammonium chloride) | Variable (C10: 311.9; C12: 340.0; C14: 368.1; C16: 396.1) |
C10: 1.74; C12: 2.63; C14: 3.52; C16: 4.41 | Yes99 |
Didecyl dimethyl ammonium chloride | 362 | 4.01 | Yes100 |
n.a., not available/unknown.
Calculated using MarvinSketch program (ChemAxon Ltd., Hungary) unless otherwise specified.
Alcohols
WHO recommends the use of alcohols, namely, ethanol (80%v/v) and isopropanol (75%v/v) in handrubs.8 Percutaneous penetration of both alcohols is generally low even with extensive use.[9], [10], [11] They may create both ICD and ACD.8 , 12 This could be related to the solvent effect on skin components (Table 2) or preirritated skin with disrupted skin barrier.13 Because isopropanol is more irritating than ethanol,14 emollients, such as glycerol or propylene glycol, may be added to hand preparations.[15], [16], [17] Allergic reactions, including contact urticarial, have been reported.[18], [19], [20] The triggers may be due to impurities, aldehyde metabolites, or fragrances in the product.19 , 21
Aldehydes
Glutaraldehyde does not readily penetrate the skin (10% glutaraldehyde: up to ~14%; 0.75% and 7.5% glutaraldehyde: ~0.2%)22 , 23; however, it is irritating and can cause necrosis at higher concentrations (20%).24 , 25 ACD frequently occurs due to occupational (1% to 2%) and experimental (1% to 10%) exposures.24 This involves a Th2-dominant cytokine expression profile with a higher interleukin-4 (IL-4) over Th1-associated interferon-γ (IFN-γ).26 Yellow-brown skin discoloration has the tanning effect from glutaraldehyde crosslinking of proteinaceous components such as keratin and collagen that alters the protein structure, thus creating yellow-brown discoloration.27
Biguanides
The dermal absorption of polyhexamethylene biguanide hydrochloride (PHMB) or polyhexanide is low (4%).28 ACD is rare (0.5%) with application of 0.4% to 0.5% PHMB, and even at 5% PHMB, the reporting remains insignificant (0.8%).29 Despite this, ACD is continually reported in recent years and has partial cross-reactivity with other biguanides such as chlorhexidine and polyaminopropylbiguanide.[30], [31], [32], [33] PHMB is recognized as a moderate-to-strong skin sensitizer at concentrations above 1.2%.34 Anaphylaxis rarely occurs and may be related to wound treatment involving damaged skin.[35], [36], [37]
Chlorine and chlorine compounds
The percutaneous penetration for hypochlorites is low and is attributed to its high reactivity, oxidizing, and alkalinity properties when in contact with proteinaceous materials.38 Hypochlorites are nonirritating when diluted (0.1%) but are skin irritants at 5% to 10%.38 , 39 Heat release from an exothermic reaction with water may worsen the reactions.40 Other skin manifestations, such as burning sensation, pain, redness, edema, blisters, and necrosis, are known.40 Beyond 10%, hypochlorites are corrosive and can cause chemical burns.
Chlorine dioxide (ClO2) is a highly reactive and unstable chlorine compound. The oxidizing effect on the skin may be similar to hypochlorites but milder even at very high concentrations considering the rapid degradation.41 Even though chlorine gas produced can be irritating to the skin, the effect is insignificant, because no dermal uptake occurs with intact human skin.42
Iodophors
Iodophors or polyvinylpyrrolidone (povidone, PVP) iodines (PVP-I) is nonstaining, being relatively less toxic and irritating, compared with iodine. Topical absorption seems to be time dependent.43 ICD (usually 10% PVP-I) sometimes occurs with chemical burns, pain, blistering lesions, and tissue necrosis.[44], [45], [46], [47], [48], [49] Such burns, however, are often observed in damaged skin and/or wounds with prolonged exposure.48 , 50 , 51 These side effects are associated with the wet condition during application and the continuous release of free iodine (I2) that act as weak oxidants such as iodine cations (H2OI+).48 ACD and anaphylactic reactions are seldom reported and mainly may be due to other ingredients such as alcohols and PVP,[52], [53], [54], [55] which can induce IgE-mediated allergic reactions.52
Metal ions
Percutaneous absorption of silver and its nanoparticle forms is usually low in both intact and damaged skin (<4%), because its ionized form does not penetrate the skin readily.56 , 57 ACD is known to occur due to the other ingredients.58 Local skin discoloration (brown-black) is occasionally observed and be seen more frequently with topical application to wounds.59 , 60 This is not true argyria (blue-grayish discoloration), which is more long-lasting and common after chronic exposure through inhalation or oral ingestion.59
α-Hydroxy acids
α-Hydroxy acids (AHAs), including citric acid (CA), glycolic acid (GA), and lactic acid (LA), can penetrate the skin, but the dermal absorption is dependent on pH, concentration, and time.[61], [62], [63], [64] Burning, dermatitis, skin peeling, itching, and moderate sunburns are frequently reported at a concentration ≤10% or a pH ≥3.5.65 This can be related to the expression of proinflammatory cytokines, such as tumor necrosis factor-α (TNF-α) and IL-1α.66 An increased epidermal and dermal thickness is common at higher concentrations (CA and GA: 20% to 40%; LA: 12%).[67], [68], [69], [70] AHA may also induce reversible skin photosensitivity and contact urticaria.61 , 71 , 72 CA and GA (≥3%) can induce apoptosis of keratinocytes that enhances photodamage to the skin.73 AHA may also decrease melanin deposition in the skin in vivo.69 , 74 AHA at lower concentrations has none of these effects and is highly useful in dermatologic practice.
Peroxygen compounds
Dermal penetration of hydrogen peroxide (H2O2) remains unknown due to the rapid degradation into oxygen and water, especially when in contact with organic materials.75 A transient skin blanching, usually benign, is often detected.76 In addition, vacuolar eruption due to oxygen bubble formation in the skin (gas embolism) is a unique clinical manifestation from an exposure of up to 35% H2O2. 77 H2O2 is usually nonirritating at a low concentration (≤10%) despite being a strong oxidizing antiseptic.75 , [78], [79], [80] At 35%, H2O2 can cause reversible erythema and edema but irreversible skin desquamation. With a concentration of more than 50%, chemical burns are usually noticed. Prolonged exposure may produce the same reactions at a lower concentration.
Skin irritation, erythema, scaling, and roughness may occur with repeated application of 0.1% to 0.2% of peracetic acid (PA).81 Acute skin irritation has been observed at 0.5% to 3%.82 A regular spray, using 0.2% to 0.5% PA during the SARS outbreak in 2002 to 2003 created multiple health hazards, including skin irritation, burning, and itching, lasting up to 5 hours.83 The cause may be due to the excellent lipid solubility of PA and its strong oxidative disruption on the skin lipids and keratin protein.
Phenolic compounds
Phenol and its derivative, especially ortho-phenylphenol (OPP) or biphenyl-2-ol and ortho-benzyl-para-chlorophenol (OBPCP), have excellent skin-penetrating power.84 , 85 Skin reactions can develop with short contact. ACD related to OPP and OBPCP may occur even at low concentrations (0.1%).[86], [87], [88] Chemical burns and digital tip gangrene have occurred after persistent exposure to 0.5% halogenated phenol; the actual causative compound was not stated.89 Depigmentation or leukoderma is another clinical concern when applying OPP and OBPCP (1%),90 , 91 although the depigmentation is reversible but with the repigmentation process taking upward to a year or more.
Surfactants
Anionic surfactants
Sodium dodecylbenzenesulfonate does not readily penetrate the skin, but penetration may happen due to prolonged contact.92 Repeated application (1%) can result in moderate to severe erythema and skin roughness.[92], [93], [94], [95], [96]
Cationic surfactants (quaternary ammonium compounds)
Benzalkonium chloride (BAC) can penetrate the skin and induce skin irritation and inflammation at low concentrations (0.1%).97 , 98 ACD is rare.99 Newer generations of quaternary ammonium compounds (QAC), dialkyl QAC, such as didecyl dimethyl ammonium chloride (DDAC), have poor cutaneous in vitro.100 ACD has been reported at very low concentrations (0.01%), and immediate hypersensitivity is possible.[101], [102], [103], [104], [105] Urticaria, swelling, erythema, and itchiness can be found at higher concentrations (1% to 10%).104 , 106 DDAC may produce mixed hypersensitivity that induces both IgE- and T-cell-mediated responses.[107], [108], [109] DDAC can be a skin irritant and sensitizer, probably stronger than BAC.
Safety preventive measures
Although the use of disinfectants is inevitable, it is crucial to consider the following points to minimize or avoid any potential dermatologic reactions:
-
•
Damaged skin is prone to adverse reactions from a direct absorption of disinfectants, and extra care should be given to avoid contact with disinfectants.
-
•
While multiple disinfectants may be used together or formulated as a single product to achieve synergistic effects, an enhanced adverse effect is expected.
-
•
Whenever dermatitis is known, disinfectants that are weak or nonirritants and sensitizers should be prioritized. Patch testing may be considered. It is important to avoid using disinfectants from a similar class that is known to be allergic to the users in consideration of a potential cross-reactivity.
-
•
It is necessary to use protective garments during handling to avoid direct contact from spillage. Even with regular use of protective attires, unnoticeable punctures in the gloves on multiple uses and the handling of disinfected surfaces can expose users to contamination. Possible interactions of disinfectants with protective garments may occur; for example, glutaraldehyde at 2% to 3.4% may penetrate latex gloves after 45 min, and thus butyl rubber and nitrile rubber gloves are recommended.110
-
•
Emphasis is given only on the dermatologic reactions in this review, but the exposure through other manners such as ocular route and inhalation is often significant and most probably toxic. For instance, chlorine compounds are known to emit chlorine gas during preparation and application. The exposure to the eyes is thus high and toxic.
Conclusions
The dermatologic events are usually, but not always, related to prolonged exposure and contact with concentrated disinfectants. Many dermatologic adverse events remain unreported. Some skin reactions, especially sensitization, can develop for compounds currently known to be a nonirritant or sensitizer.
Declaration of Competing Interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
References
- 1.World Health Organization . March 11, 2020. WHO virtual press conference on COVID-19.https://www.who.int/docs/default-source/coronaviruse/transcripts/who-audio-emergencies-coronavirus-press-conference-full-and-final-11mar2020.pdf?sfvrsn=cb432bb3_2 [Google Scholar]
- 2.Lachapelle J.M. A comparison of the irritant and allergenic properties of antiseptics. Eur J Dermatol. 2014;24:3–9. doi: 10.1684/ejd.2013.2198. [DOI] [PubMed] [Google Scholar]
- 3.Lee H.Y., Stieger M., Yawalkar N., et al. Cytokines and chemokines in irritant contact dermatitis. Mediat Inflamm. 2013;2013:916497. doi: 10.1155/2013/916497. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Sebastiani S., Albanesi C., De Pità O., et al. The role of chemokines in allergic contact dermatitis. Arch Dermatol Res. 2002;293:552–559. doi: 10.1007/s00403-001-0276-9. [DOI] [PubMed] [Google Scholar]
- 5.Nosbaum A., Nicolas J.-F. In: Textbook of Hand Eczema. Alikhan A., Lachapelle J.-M., Maibach H.I., editors. Springer; Berlin: 2014. Irritant versus allergic contact dermatitis: an etiopathological approach; pp. 69–74. [Google Scholar]
- 6.European Chemicals Agency . Helsinki; European Chemicals Agency: 2020. COVID-19 Lists of Disinfectant Active Substances and Products.https://data.europa.eu/euodp/en/data/dataset/biocidal-products-lists-of-disinfectant-active-substances-and-products [Google Scholar]
- 7.US Environmental Protection Agency . US Environmental Protection Agency; Washington, DC: 2020. List N: Disinfectants for Use Against SARS-CoV-2.https://www.epa.gov/pesticide-registration/list-n-disinfectants-coronavirus-covid-19 [Google Scholar]
- 8.World Health Organization . WHO Press; Geneva: 2009. WHO Guidelines on Hand Hygiene in Health Care. [Google Scholar]
- 9.Blank I.H. Penetration of low-molecular-weight alcohols into skin. I. Effect of concentration of alcohol and type of vehicle. J Invest Dermatol. 1964;43:415–420. doi: 10.1038/jid.1964.174. [DOI] [PubMed] [Google Scholar]
- 10.Pendlington R.U., Whittle E., Robinson J.A., et al. Fate of ethanol topically applied to skin. Food Chem Toxicol. 2001;39:169–174. doi: 10.1016/s0278-6915(00)00120-4. [DOI] [PubMed] [Google Scholar]
- 11.Kramer A., Below H., Bieber N., et al. Quantity of ethanol absorption after excessive hand disinfection using three commercially available hand rubs is minimal and below toxic levels for humans. BMC Infect Dis. 2007;7:117. doi: 10.1186/1471-2334-7-117. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Lachenmeier D.W. Safety evaluation of topical applications of ethanol on the skin and inside the oral cavity. J Occup Med Toxicol. 2008;3:26. doi: 10.1186/1745-6673-3-26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Löffler H., Kampf G. Hand disinfection: how irritant are alcohols? J Hosp Infect. 2008;70:44–48. doi: 10.1016/S0195-6701(08)60010-9. [DOI] [PubMed] [Google Scholar]
- 14.de Haan P., Meester H.H.M., Bruynzeel D.P. In: The Irritant Contact Dermatitis Syndrome. Van der Valk P., Maibach H., editors. CR Press; New York: 1996. Irritancy of alcohols; pp. 65–70. [Google Scholar]
- 15.Goh C.F., Mohamed Ahmed A.H.A. How to make hand sanitiser gel. Commun Eye Health J. 2020;33:16. [PMC free article] [PubMed] [Google Scholar]
- 16.Mohamed Ahmed A.H.A., Goh C.F. How to make hand sanitiser/hand rub. Commun Eye Health J. 2020;33:14–15. [PMC free article] [PubMed] [Google Scholar]
- 17.Berardi A., Perinelli D.R., Merchant H.A., et al. Hand sanitisers amid CoViD-19: a critical review of alcohol-based products on the market and formulation approaches to respond to increasing demand. Int J Pharm. 2020;584:119431. doi: 10.1016/j.ijpharm.2020.119431. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Pecquet C., Pradalier A., Dry J. Allergic contact dermatitis from ethanol in a transdermal estradiol patch. Contact Dermat. 1992;27:275. doi: 10.1111/j.1600-0536.1992.tb03276.x. [DOI] [PubMed] [Google Scholar]
- 19.Barbaud A., Trechot P., Reichert-Penetrat S., et al. Contact dermatitis due to ethyl alcohol: how to perform patch tests? Ann Dermatol Venereol. 2000;1339:469–549. [PubMed] [Google Scholar]
- 20.Cimiotti J.P., Marmur E.S., Nesin M., et al. Adverse reactions associated with an alcohol-based hand antiseptic among nurses in a neonatal intensive care unit. Am J Infect Control. 2003;31:43–48. doi: 10.1067/mic.2003.42. [DOI] [PubMed] [Google Scholar]
- 21.Ophaswongse S., Maibach H.I. Alcohol dermatitis: allergic contact dermatitis and contact urticaria syndrome. Contact Dermat. 1994;30:1–6. doi: 10.1111/j.1600-0536.1994.tb00719.x. [DOI] [PubMed] [Google Scholar]
- 22.Reifenrath W.G., Prystowsky S.D., Nonomura J.H., et al. Topical glutaraldehyde-percutaneous penetration and skin irritation. Arch Dermatol Res. 1985;277:242–244. doi: 10.1007/BF00404324. [DOI] [PubMed] [Google Scholar]
- 23.Frantz S.W., Beskitt J.L., Tallant M.J., et al. Glutaraldehyde: species comparisons of in vitro skin penetration. J Toxicol Cutan Ocul Toxicol. 1993;12:349–361. [Google Scholar]
- 24.Takigawa T., Endo Y. Effects of glutaraldehyde exposure on human health. J Occup Health. 2006;48:75–87. doi: 10.1539/joh.48.75. [DOI] [PubMed] [Google Scholar]
- 25.Beauchamp R.O., St Clair M.B.G., Fennell T.R., et al. A critical review of the toxicology of glutaraldehyde. Crit Rev Toxicol. 1992;22:143–174. doi: 10.3109/10408449209145322. [DOI] [PubMed] [Google Scholar]
- 26.van Triel J.J., van Bree B.W.J., Roberts D.W., et al. The respiratory allergen glutaraldehyde in the local lymph node assay: sensitization by skin exposure, but not by inhalation. Toxicology. 2011;279:115–122. doi: 10.1016/j.tox.2010.09.018. [DOI] [PubMed] [Google Scholar]
- 27.Ruijgrok J.M., de Wijn J.R., Boon M.E. Glutaraldehyde crosslinking of collagen: effects of time, temperature, concentration and presoaking as measured by shrinkage temperature. Clin Mater. 1994;17:23–27. doi: 10.1016/0267-6605(94)90044-2. [DOI] [PubMed] [Google Scholar]
- 28.Scientific Committee on Consumer Safety . European Comission; Luxembourg: 2017. Opinion on Polyaminopropyl Biguanide (PHMB) - Submission III. [Google Scholar]
- 29.Schnuch A., Geier J., Uter W., et al. The biocide polyhexamethylene biguanide remains an uncommon contact allergen. Contact Dermat. 2007;56:235–239. doi: 10.1111/j.1600-0536.2007.01089.x. [DOI] [PubMed] [Google Scholar]
- 30.Aerts O., Smeets J., Adriaenssens K., et al. Contact allergy to biguanides might explain cases of unresolved eyelid dermatitis. J Eur Acad Dermatol Venereol. 2015;29:2064–2065. doi: 10.1111/jdv.12598. [DOI] [PubMed] [Google Scholar]
- 31.Pummi K., Kemppi E., Lammintausta K. Occupational sensitization to polyhexamethylene guanidine hydrochloride in a non-alcoholic hand rub. Contact Dermat. 2012;66:348–349. doi: 10.1111/j.1600-0536.2012.02017.x. [DOI] [PubMed] [Google Scholar]
- 32.Leysen J., Goossens A., Lambert J., et al. Polyhexamethylene biguanide is a relevant sensitizer in wet wipes. Contact Dermat. 2014;70:323–325. doi: 10.1111/cod.12208. [DOI] [PubMed] [Google Scholar]
- 33.Pastor-Nieto M.-A., González-Muñoz P., Pérez-Mesonero R., et al. Allergic contact dermatitis caused by poly(hexamethylene) biguanide hydrochloride in contact lens care solutions. Contact Dermat. 2017;76:373–376. doi: 10.1111/cod.12730. [DOI] [PubMed] [Google Scholar]
- 34.Assessment Report - Polyhexamethylene Biguanide (Mn = 1415; PDI =4.7). Regulation (EU) No 528/2012 concerning the making available on the market and use of biocidal products. European Commission; France: 2017. [Google Scholar]
- 35.Schunter J.A., Stöcker B., Brehler R. A case of severe anaphylaxis to polyhexanide: cross-reactivity between biguanide antiseptics. Int Arch Allergy Immunol. 2017;173:233–236. doi: 10.1159/000478700. [DOI] [PubMed] [Google Scholar]
- 36.Olivieri J., Eigenmann P.A., Hauser C. Severe anaphylaxis to a new disinfectant: polyhexanide, a chlorhexidine polymer. Schweiz Med Wochenschr. 1998;128:1508–1511. [PubMed] [Google Scholar]
- 37.Kautz O., Schumann H., Degerbeck F., et al. Severe anaphylaxis to the antiseptic polyhexanide. Allergy. 2010;65:1068–1070. doi: 10.1111/j.1398-9995.2009.02299.x. [DOI] [PubMed] [Google Scholar]
- 38.Assessment Report - Active Chlorine Released from Sodium Hypochlorite. Regulation (EU) No 528/2012 concerning the making available on the market and use of biocidal products. Europe Commission; Italy: 2017. [Google Scholar]
- 39.Bruch M. Toxicity and safety of topical sodium hypochlorite. Contrib Nephrol. 2007;154:24–38. doi: 10.1159/000096812. [DOI] [PubMed] [Google Scholar]
- 40.Slaughter R.J., Watts M., Vale J.A., et al. The clinical toxicology of sodium hypochlorite. Clin Toxicol. 2019;57:303–311. doi: 10.1080/15563650.2018.1543889. [DOI] [PubMed] [Google Scholar]
- 41.Toxicological Profile for Chlorine Dioxide and Chlorite. US Agency for Toxic Substances and Disease Registry; Atlanta: 2004. [PubMed] [Google Scholar]
- 42.Gaskin S., Pisaniello D., Edwards J.W., et al. Chlorine and hydrogen cyanide gas interactions with human skin: in vitro studies to inform skin permeation and decontamination in HAZMAT incidents. J Hazard Mater. 2013;262:759–765. doi: 10.1016/j.jhazmat.2013.09.040. [DOI] [PubMed] [Google Scholar]
- 43.Nesvadbova M., Crosera M., Maina G., et al. Povidone iodine skin absorption: an ex-vivo study. Toxicol Lett. 2015;235:155–160. doi: 10.1016/j.toxlet.2015.04.004. [DOI] [PubMed] [Google Scholar]
- 44.Liu F.C., Liou J.T., Hui Y.L., et al. Chemical burn caused by povidone-iodine alcohol solution—a case report. Acta Anaesthesiol Sin. 2003;41:93–96. [PubMed] [Google Scholar]
- 45.Nahlieli O., Baruchin A.M., Levi D., et al. Povidone-iodine related burns. Burns. 2001;27:185–188. doi: 10.1016/s0305-4179(00)00081-4. [DOI] [PubMed] [Google Scholar]
- 46.Chiang Y.C., Lin T.S., Yeh M.C. Povidone-iodine-related burn under the tourniquet of a child—a case report and literature review. J Plast Reconstr Aesthet Surg. 2011;64:412–415. doi: 10.1016/j.bjps.2010.04.032. [DOI] [PubMed] [Google Scholar]
- 47.Murthy M.B., Krishnamurthy B. Severe irritant contact dermatitis induced by povidone iodine solution. Indian J Pharmacol. 2009;41:199–200. doi: 10.4103/0253-7613.56069. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Iijima S., Kuramochi M. Investigation of irritant skin reaction by 10% povidone-iodine solution after surgery. Dermatology (Basel, Switzerland) 2002;204(suppl 1):103–108. doi: 10.1159/000057736. [DOI] [PubMed] [Google Scholar]
- 49.Rees A., Sherrod Q., Young L. Chemical burn from povidone-iodine: case and review. J Drugs Dermatol. 2011;10:414–417. [PubMed] [Google Scholar]
- 50.Kambara Y., Hiramatsu K., Kato T., et al. Randomized clinical trial of single skin sterilization with a povidone-iodine applicator versus conventional skin sterilization in abdominal surgery. BJS Open. 2019;3:282–287. doi: 10.1002/bjs5.50144. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Borrego L., Hernández N., Hernández Z., et al. Povidone-iodine induced post-surgical irritant contact dermatitis localized outside of the surgical incision area. Report of 27 cases and a literature review. Int J Dermatol. 2016;55:540–545. doi: 10.1111/ijd.12957. [DOI] [PubMed] [Google Scholar]
- 52.Adachi A., Fukunaga A., Hayashi K., et al. Anaphylaxis to polyvinylpyrrolidone after vaginal application of povidone-iodine. Contact Dermat. 2003;48:133–136. doi: 10.1034/j.1600-0536.2003.00050.x. [DOI] [PubMed] [Google Scholar]
- 53.Waran K., Munsick R. Anaphylaxis from povidone-iodine. Lancet. 1995;345:1506. doi: 10.1016/s0140-6736(95)91063-8. [DOI] [PubMed] [Google Scholar]
- 54.Marks J.G., Jr. Allergic contact dermatitis to povidone-iodine. J Am Acad Dermatol. 1982;6:473–475. doi: 10.1016/s0190-9622(82)80363-0. [DOI] [PubMed] [Google Scholar]
- 55.Niedner R. Cytotoxicity and sensitization of povidone-iodine and other frequently used anti-infective agents. Dermatology. 1997;195(suppl 2):89–92. doi: 10.1159/000246038. [DOI] [PubMed] [Google Scholar]
- 56.Lansdown A.B..G. Royal Society of Chemistry; Cambridge, UK: 2010. Silver in Healthcare: Its Antimicrobial Efficacy and Safety in Use. [Google Scholar]
- 57.Larese F.F., D’Agostin F., Crosera M., et al. Human skin penetration of silver nanoparticles through intact and damaged skin. Toxicology. 2009;255:33–37. doi: 10.1016/j.tox.2008.09.025. [DOI] [PubMed] [Google Scholar]
- 58.Group A, Lea A. Contact dermatitis with a highlight on silver: a review. Wounds. 2010;22:311–315. [PubMed] [Google Scholar]
- 59.Lansdown ABG A pharmacological and toxicological profile of silver as an antimicrobial agent in medical devices. Adv Pharmacol Sci. 2010;2010:910686. doi: 10.1155/2010/910686. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Isak V., Beerli T., Cozzio A., et al. A rare case of localized argyria on the face. Case Rep Dermatol. 2019;11:23–27. doi: 10.1159/000494610. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Andersen F.A. Final report on the safety assessment of glycolic acid, ammonium, calcium, potassium, and sodium glycolates, methyl, ethyl, propyl, and butyl glycolates, and lactic acid, ammonium, calcium, potassium, sodium, and tea-lactates, methyl, ethyl, isopropyl, and butyl lactates, and lauryl, myristyl, and cetyl lactates. Int J Toxicol. 1998;17:1–241. [Google Scholar]
- 62.Jiang M., Qureshi S.A. Assessment of in vitro percutaneous absorption of glycolic acid through human skin sections using a flow-through diffusion cell system. J Dermatol Sci. 1998;18:181–188. doi: 10.1016/s0923-1811(98)00039-5. [DOI] [PubMed] [Google Scholar]
- 63.Kraeling M., Bronaugh R. In vitro percutaneous absorption of alpha hydroxy acids in human skin. J Cosmet Sci. 1997;48:187–197. [Google Scholar]
- 64.Okuda M., Donahue D.A., Kaufman L.E., et al. Negligible penetration of incidental amounts of alpha-hydroxy acid from rinse-off personal care products in human skin using an in vitro static diffusion cell model. Toxicol in Vitro. 2011;25:2041–2047. doi: 10.1016/j.tiv.2011.08.005. [DOI] [PubMed] [Google Scholar]
- 65.US Food and Drug Agency . U.S Food and Drug Agency; College Park, MD: 2005. Guidance for Industry: Labeling for Cosmetics Containing Alpha Hydroxy Acids. [Google Scholar]
- 66.Jeong S.K., Ko J.Y., Seo J.T., et al. Stimulation of epidermal calcium gradient loss and increase in TNF-α and IL-1α expressions by glycolic acid in murine epidermis. Exp Dermatol. 2005;14:571–579. doi: 10.1111/j.0906-6705.2005.00308.x. [DOI] [PubMed] [Google Scholar]
- 67.Bernstein E.F., Underbill C.B., Lakkakorpi J., et al. Citric acid increases viable epidermal thickness and glycosaminoglycan content of sundamaged skin. Dermatol Surg. 1997;23:689–694. doi: 10.1111/j.1524-4725.1997.tb00391.x. [DOI] [PubMed] [Google Scholar]
- 68.Bernstein E.F., Lee J., Brown D.B., et al. Glycolic acid treatment increases type I collagen mRNA and hyaluronic acid content of human skin. Dermatol Surg. 2001;27:429–433. doi: 10.1046/j.1524-4725.2001.00234.x. [DOI] [PubMed] [Google Scholar]
- 69.Yamamoto Y., Uede K., Yonei N., et al. Effects of alpha-hydroxy acids on the human skin of Japanese subjects: the rationale for chemical peeling. J Dermatol. 2006;33:16–22. doi: 10.1111/j.1346-8138.2006.00003.x. [DOI] [PubMed] [Google Scholar]
- 70.Smith W.P. Epidermal and dermal effects of topical lactic acid. J Am Acad Dermatol. 1996;35:388–391. doi: 10.1016/s0190-9622(96)90602-7. [DOI] [PubMed] [Google Scholar]
- 71.Kaidbey K., Sutherland B., Bennett P., et al. Topical glycolic acid enhances photodamage by ultraviolet light. Photodermatol Photoimmunol Photomed. 2003;19:21–27. doi: 10.1034/j.1600-0781.2003.00013.x. [DOI] [PubMed] [Google Scholar]
- 72.Vishal B., Rao S.S., Pavithra S., et al. Contact urticaria to glycolic acid peel. J Cutan Aesthet Surg. 2012;5:58–59. doi: 10.4103/0974-2077.94334. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Tang S.-C., Yang J.-H. Dual effects of alpha-hydroxy acids on the skin. Molecules. 2018;23:863. doi: 10.3390/molecules23040863. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Usuki A., Ohashi A., Sato H., et al. The inhibitory effect of glycolic acid and lactic acid on melanin synthesis in melanoma cells. Exp Dermatol. 2003;12:43–50. doi: 10.1034/j.1600-0625.12.s2.7.x. [DOI] [PubMed] [Google Scholar]
- 75.Assessment Report - Hydrogen Peroxide. Regulation (EU) No 528/2012 concerning the making available on the market and use of biocidal products. European Commission; Finland: 2015. [Google Scholar]
- 76.Chan H.P., Maibach H.I. Hydrogen peroxide, blanching, and skin: an overview. Cutan Ocul Toxicol. 2008;27:307–309. doi: 10.1080/15569520802340396. [DOI] [PubMed] [Google Scholar]
- 77.Izu K., Yamamoto O., Asahi M. Occupational skin injury by hydrogen peroxide. Dermatology. 2000;201:61–64. doi: 10.1159/000018434. [DOI] [PubMed] [Google Scholar]
- 78.European Union Risk Assessment Report - Hydrogen Peroxide. European Communities; Helsinki: 2003. [Google Scholar]
- 79.Bito T., Izu K., Tokura Y. Evaluation of toxicity and Stat3 activation induced by hydrogen peroxide exposure to the skin in healthy individuals. J Dermatol Sci. 2010;58:157–159. doi: 10.1016/j.jdermsci.2010.03.013. [DOI] [PubMed] [Google Scholar]
- 80.Murphy E.C., Friedman A.J. Hydrogen peroxide and cutaneous biology: translational applications, benefits, and risks. J Am Acad Dermatol. 2019;81:1379–1386. doi: 10.1016/j.jaad.2019.05.030. [DOI] [PubMed] [Google Scholar]
- 81.The MAK-Collection for Occupational Health and Safety. Wiley; Weinheim, Germany: 1996. Peracetic acid [MAK value documentation, 1996] pp. 230–239. [Google Scholar]
- 82.Peracetic Acid Acute Exposure Guideline Levels Acute Exposure Guideline Levels for Selected Airborne Chemicals by National Research Council (US) Committee on Acute Exposure Guideline Levels. National Academies Press; Washington, DC: 2010. pp. 327–367. [Google Scholar]
- 83.You Y., Bai Z., Yan L., et al. Peracetic acid exposure assessment during outbreak of SARS in Tianjin, China [Abstract] Epidemiology. 2006;17:S217–S218. [Google Scholar]
- 84.Roberts M.S., Anderson R.A. The percutaneous absorption of phenolic compounds: the effect of vehicles on the penetration of phenol. J Pharm Pharmacol. 1975;27:599–605. doi: 10.1111/j.2042-7158.1975.tb09513.x. [DOI] [PubMed] [Google Scholar]
- 85.Hinz R.S., Lorence C.R., Hodson C.D., et al. Percutaneous penetration of para-substituted phenols in vitro. Fundam Appl Toxicol. 1991;17:575–583. doi: 10.1016/0272-0590(91)90207-k. [DOI] [PubMed] [Google Scholar]
- 86.Sonnex T.S., Rycroft R.J.G. Allergic contact dermatitis from orthobenzyl parachlorophenol in a drinking glass cleaner. Contact Dermat. 1986;14:247–248. doi: 10.1111/j.1600-0536.1986.tb01235.x. [DOI] [PubMed] [Google Scholar]
- 87.Adams R.M. Allergic contact dermatitis due to o-phenylphenol. Contact Dermat. 1981;7:332. doi: 10.1111/j.1600-0536.1981.tb04093.x. [DOI] [PubMed] [Google Scholar]
- 88.Estlander T., Kanerva L., Jolanki R. In: Current Topics in Contact Dermatitis. Frosch P., Dooms-Goossens A., Lachapelle J.M., et al., editors. Springer; Berlin: 1989. Occupational skin sensitization to the antimicrobials ortho-benzyl para-chlorophenol and ampholyte 103 G; pp. 88–91. [Google Scholar]
- 89.DeBono R., Laitung G. Phenolic household disinfectants—further precautions required. Burns. 1997;23:182–185. doi: 10.1016/s0305-4179(96)00114-3. [DOI] [PubMed] [Google Scholar]
- 90.Kahn G. Depigmentation caused by phenolic detergent germicides. Arch Dermatol. 1970;102:177–187. [PubMed] [Google Scholar]
- 91.Arundell F.D. San Francisco Dermatological Society. Arch Dermatol. 1973;108:848–849. [Google Scholar]
- 92.Final report on the safety assessment of sodium dodecylbenzenesulfonate/TEA-dodecylbenzenesulfonate/ sodium decylbenzenesulfonateJ Am Coll Toxicol. 1993;12:279–309. [Google Scholar]
- 93.Prottey C., Ferguson T. Factors which determine the skin irritation potential of soaps and detergents. J Soc Cosmet Chem. 1975;26:29–46. [Google Scholar]
- 94.Harrold S. Denaturation of epidermal keratin by surface active agents. J Invest Dermatol. 1959;32:581–588. doi: 10.1038/jid.1959.97. [DOI] [PubMed] [Google Scholar]
- 95.Van Scott E.J., Lyon J.B. A chemical measure of the effect of soaps and detergents on the skin. J Invest Dermatol. 1953;21:199–203. doi: 10.1038/jid.1953.90. [DOI] [PubMed] [Google Scholar]
- 96.Imokawa G., Sumura K., Katsumi M. Study on skin roughness caused by surfactants: II. Correlation between protein denaturation and skin roughness. J Am Oil Chem Soc. 1975;52:484–489. doi: 10.1007/BF02640737. [DOI] [PubMed] [Google Scholar]
- 97.Aki H., Koizumi E., Okamoto Y., et al. Interaction of stratum corneum components with benzalkonium chloride. Isothermal Titration Calorimetric Study. J Therm Anal Calorimetry. 2001;64:293–297. [Google Scholar]
- 98.Basketter D.A., Marriott M., Gilmour N.J., et al. Strong irritants masquerading as skin allergens: the case of benzalkonium chloride. Contact Dermat. 2004;50:213–217. doi: 10.1111/j.0105-1873.2004.00331.x. [DOI] [PubMed] [Google Scholar]
- 99.Wentworth A.B.., Yiannias J.A., Davis M.D.P., et al. Benzalkonium chloride: a known irritant and novel allergen. Dermatitis. 2016;27:14–20. doi: 10.1097/DER.0000000000000160. [DOI] [PubMed] [Google Scholar]
- 100.Buist H.E., de Heer C., van Burgsteden J.A., et al. Dermatokinetics of didecyldimethylammonium chloride and the influence of some commercial biocidal formulations on its dermal absorption in vitro. Regul Toxicol Pharmacol. 2007;48:87–92. doi: 10.1016/j.yrtph.2007.01.007. [DOI] [PubMed] [Google Scholar]
- 101.Dejobert Y., Martin P., Piette E., et al. Contact dermatitis from didecyldimethylammonium chloride and bis-(aminopropyl)-laurylamine in a detergent-disinfectant used in hospital. Contact Dermat. 1997;37:95. doi: 10.1111/j.1600-0536.1997.tb00050.x. [DOI] [PubMed] [Google Scholar]
- 102.Mowitz M., Pontén A. Foot dermatitis caused by didecyldimethylammonium chloride in a shoe refresher spray. Contact Dermat. 2015;73:374–376. doi: 10.1111/cod.12456. [DOI] [PubMed] [Google Scholar]
- 103.Geier J., Lessmann H., Cevik N., et al. Patch testing with didecyldimethylammonium chloride. Contact Dermat. 2016;74:374–376. doi: 10.1111/cod.12539. [DOI] [PubMed] [Google Scholar]
- 104.Houtappel M., Bruijnzeel-Koomen C.A.F.M., Röckmann H. Immediate-type allergy by occupational exposure to didecyl dimethyl ammonium chloride. Contact Dermat. 2008;59:116–117. doi: 10.1111/j.1600-0536.2008.01336.x. [DOI] [PubMed] [Google Scholar]
- 105.Dibo M., Brasch J. Occupational allergic contact dermatitis from N,N-bis(3-aminopropyl)dodecylamine and dimethyldidecylammonium chloride in 2 hospital staff. Contact Dermat. 2001;45:40. doi: 10.1034/j.1600-0536.2001.045001040.x. [DOI] [PubMed] [Google Scholar]
- 106.Ruiz Oropeza A., Fischer Friis U., Duus Johansen J. Occupational contact urticaria caused by didecyl dimethyl ammonium chloride. Contact Dermat. 2011;64:297–298. doi: 10.1111/j.1600-0536.2011.01882.x. [DOI] [PubMed] [Google Scholar]
- 107.Shane H.L., Lukomska E., Stefaniak A.B.., et al. Divergent hypersensitivity responses following topical application of the quaternary ammonium compound, didecyldimethylammonium bromide. J Immunotoxicol. 2017;14:204–214. doi: 10.1080/1547691X.2017.1397826. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108.Anderson S.E., Shane H., Long C., et al. Evaluation of the irritancy and hypersensitivity potential following topical application of didecyldimethylammonium chloride. J Immunotoxicol. 2016;13:557–566. doi: 10.3109/1547691X.2016.1140854. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109.Shane H.L., Lukomska E., Kashon M.L., et al. Topical application of the quaternary ammonium compound didecyldimethylammonium chloride activates type 2 innate lymphoid cells and initiates a mixed-type allergic response. Toxicol Sci. 2019;168:508–518. doi: 10.1093/toxsci/kfz002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 110.Jordan S.L., Stowers M.F., Trawick E.G., et al. Glutaraldehyde permeation: choosing the proper glove. Am J Infect Control. 1996;24:67–69. doi: 10.1016/s0196-6553(96)90001-2. [DOI] [PubMed] [Google Scholar]
- 111.Kownatzki E. Hand hygiene and skin health. J Hosp Infect. 2003;55:239–245. doi: 10.1016/j.jhin.2003.08.018. [DOI] [PubMed] [Google Scholar]
- 112.Kurihara-Bergstrom T., Knutson K., DeNoble L.J., et al. Percutaneous absorption enhancement of an ionic molecule by ethanol–water systems in human skin. Pharm Res. 1990;7:762–766. doi: 10.1023/a:1015879925147. [DOI] [PubMed] [Google Scholar]
- 113.Bommannan D., Potts R.O., Guy R.H. Examination of the effect of ethanol on human stratum corneum in vivo using infrared spectroscopy. J Control Release. 1991;16:299–304. [Google Scholar]
- 114.Berner B., Juang R.-H., Mazzenga G.C. Ethanol and water sorption into stratum corneum and model systems. J Pharm Sci. 1989;78:472–476. doi: 10.1002/jps.2600780611. [DOI] [PubMed] [Google Scholar]
- 115.Brinkmann I., Müller-Goymann C.C. Role of isopropyl myristate, isopropyl alcohol and a combination of both in hydrocortisone permeation across the human stratum corneum. Skin Pharmacol Physiol. 2003;16:393–404. doi: 10.1159/000072935. [DOI] [PubMed] [Google Scholar]
- 116.Goates C.Y., Knutson K. Enhanced permeation of polar compounds through human epidermis. I. Permeability and membrane structural changes in the presence of short chain alcohols. Biochim Biophys Acta Biomembr. 1994;1195:169–179. doi: 10.1016/0005-2736(94)90024-8. [DOI] [PubMed] [Google Scholar]
- 117.Hawkins C.L., Pattison D.I., Davies M.J. Hypochlorite-induced oxidation of amino acids, peptides and proteins. Amino Acids. 2003;25:259–274. doi: 10.1007/s00726-003-0016-x. [DOI] [PubMed] [Google Scholar]
- 118.Schröter J., Schiller J. Chlorinated phospholipids and fatty acids: (patho)physiological relevance, potential toxicity, and analysis of lipid chlorohydrins. Oxidative Med Cell Longev. 2016;2016:8386362. doi: 10.1155/2016/8386362. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119.Thiele J.J., Hsieh S.N., Briviba K., et al. Protein oxidation in human stratum corneum: susceptibility of keratins to oxidation in vitro and presence of a keratin oxidation gradient in vivo. J Invest Dermatol. 1999;113:335–339. doi: 10.1046/j.1523-1747.1999.00693.x. [DOI] [PubMed] [Google Scholar]
- 120.The MAK-Collection for Occupational Health and Safety. Wiley; Weinheim, Germany: 2007. Triethylene glycol [MAK value documentation, 2007] pp. 1–25. [Google Scholar]
- 121.Lee E., An S., Cho S.A., et al. The influence of alkane chain length on the skin irritation potential of 1,2-alkanediols. Int J Cosmet Sci. 2011;33:421–425. doi: 10.1111/j.1468-2494.2011.00646.x. [DOI] [PubMed] [Google Scholar]
- 122.Johnson W., Bergfeld W.F., Belsito D.V., et al. Safety assessment of 1,2-glycols as used in cosmetics. Int J Toxicol. 2012;31:147S–168S. doi: 10.1177/1091581812460409. [DOI] [PubMed] [Google Scholar]
- 123.Warner K.S., Li S.K., Higuchi W.I. Influences of alkyl group chain length and polar head group on chemical skin permeation enhancement. J Pharm Sci. 2001;90:1143–1153. doi: 10.1002/jps.1068. [DOI] [PubMed] [Google Scholar]
- 124.Lachapelle J.M. Allergic contact dermatitis from povidone-iodine: a re-evaluation study. Contact Dermat. 2005;52:9–10. doi: 10.1111/j.0105-1873.2005.00479.x. [DOI] [PubMed] [Google Scholar]
- 125.Fiume M.M., Heldreth B.A., Bergfeld W.F., et al. Safety assessment of citric acid, inorganic citrate salts, and alkyl citrate esters as used in cosmetics. Int J Toxicol. 2014;33:16s–46s. doi: 10.1177/1091581814526891. [DOI] [PubMed] [Google Scholar]
- 126.Wang X. A theory for the mechanism of action of the alpha-hydroxy acids applied to the skin. Med Hypotheses. 1999;53:380–382. doi: 10.1054/mehy.1998.0788. [DOI] [PubMed] [Google Scholar]
- 127.Wahlberg J.E., Lindberg M. Nonanoic acid - an experimental irritant. Contact Dermat. 2003;49:117–123. doi: 10.1111/j.0105-1873.2003.00208.x. [DOI] [PubMed] [Google Scholar]
- 128.Kellum R.E. Acne vulgaris: studies in pathogenesis: relative irritancy of free fatty acids from C2 to C16. Arch Dermatol. 1968;97:722–726. doi: 10.1001/archderm.97.6.722. [DOI] [PubMed] [Google Scholar]
- 129.Johnson W., Heldreth Bart, et al. Final report of the Cosmetic Ingredient Review Expert Panel on the Safety Assessment of Pelargonic Acid (Nonanoic Acid) and Nonanoate Esters. Int J Toxicol. 2011;30:228S–269S. doi: 10.1177/1091581811428980. [DOI] [PubMed] [Google Scholar]
- 130.Forsey R.J., Shahidullah H., Sands C., et al. Epidermal Langerhans cell apoptosis is induced in vivo by nonanoic acid but not by sodium lauryl sulphate. Br J Dermatol. 1998;139:453–461. doi: 10.1046/j.1365-2133.1998.02409.x. [DOI] [PubMed] [Google Scholar]
- 131.Tanojo H., Bouwstra J.A., Junginger H.E., et al. In vitro human skin barrier modulation by fatty acids: skin permeation and thermal analysis studies. Pharm Res. 1997;14:42–49. doi: 10.1023/a:1012099216060. [DOI] [PubMed] [Google Scholar]
- 132.Zonios G., Dimou A., Galaris D. Probing skin interaction with hydrogen peroxide using diffuse reflectance spectroscopy. Phys Med Biol. 2007;53:269–278. doi: 10.1088/0031-9155/53/1/019. [DOI] [PubMed] [Google Scholar]
- 133.Scientific Committee on Consumer Safety . European Commission; Luxembourg: 2015. Opinion on o-Phenylphenol, Sodium o-Phenylphenate and Potassium o-Phenylphenate. [DOI] [PubMed] [Google Scholar]
- 134.McGuire J., Hendee J. Biochemical basis for depigmentation of skin by phenolic germicides. J Invest Dermatol. 1971;57:256–261. doi: 10.1111/1523-1747.ep12261579. [DOI] [PubMed] [Google Scholar]
- 135.Tisserand R., Young R. In: Essential Oil Safety. 2nd ed. Tisserand R., Young R., editors. Churchill Livingstone; St. Louis: 2014. Toxicity; pp. 23–38. [Google Scholar]
- 136.Chantasart D., Pongjanyakul T., Higuchi W.I., et al. Effects of oxygen-containing terpenes as skin permeation enhancers on the lipoidal pathways of human epidermal membrane. J Pharm Sci. 2009;98:3617–3632. doi: 10.1002/jps.21666. [DOI] [PubMed] [Google Scholar]
- 137.El-Kattan A.F., Asbill C.S., Michniak B.B. The effect of terpene enhancer lipophilicity on the percutaneous permeation of hydrocortisone formulated in HPMC gel systems. Int J Pharm. 2000;198:179–189. doi: 10.1016/s0378-5173(00)00330-6. [DOI] [PubMed] [Google Scholar]
- 138.Roberts M.S., Anderson R.A., Swarbrick J. Permeability of human epidermis to phenolic compounds. J Pharm Pharmacol. 1977;29:677–683. doi: 10.1111/j.2042-7158.1977.tb11434.x. [DOI] [PubMed] [Google Scholar]
- 139.Final report on the safety assessment of p-chloro-m-cresolInt J Toxicol. 1997;16:235–268. [Google Scholar]
- 140.Gotter B., Faubel W., Neubert R.H.H. FTIR microscopy and confocal Raman microscopy for studying lateral drug diffusion from a semisolid formulation. Eur J Pharm Biopharm. 2010;74:14–20. doi: 10.1016/j.ejpb.2009.07.006. [DOI] [PubMed] [Google Scholar]
- 141.Freitas J.P., Brandão F.M. Contact urticaria to chlorocresol. Contact Dermat. 1986;15:252. doi: 10.1111/j.1600-0536.1986.tb01353.x. [DOI] [PubMed] [Google Scholar]
- 142.Mehrtens S.H., Reckling C. Contact urticaria with anaphylaxis caused by chlorocresol, chloroxylenol, and thiourea. Contact Dermat. 2019;80:311–313. doi: 10.1111/cod.13194. [DOI] [PubMed] [Google Scholar]
- 143.Becker L.C., Bergfeld W.F., Belsito D.V., et al. Amended safety assessment of dodecylbenzenesulfonate, decylbenzenesulfonate, and tridecylbenzenesulfonate salts as used in cosmetics. Int J Toxicol. 2010;29:288S–305S. doi: 10.1177/1091581810386124. [DOI] [PubMed] [Google Scholar]
- 144.Bartnik F., Künstler K. In: Surfactants in Consumer Products. Falbe J., editor. Springer-Verlag; Berlin: 1987. Biological effects, toxicology and human safety; pp. 475–503. [Google Scholar]
- 145.Froebe C.L., Simion F.A., Rhein L.D., et al. Stratum corneum lipid removal by surfactants: relation to in vivo irritation. Dermatologica. 1990;181:277–283. doi: 10.1159/000247822. [DOI] [PubMed] [Google Scholar]
- 146.Uter W., Lessmann H., Geier J., et al. Is the irritant benzalkonium chloride a contact allergen? A contribution to the ongoing debate from a clinical perspective. Contact Dermat. 2008;58:359–363. doi: 10.1111/j.1600-0536.2008.01327.x. [DOI] [PubMed] [Google Scholar]
- 147.Fuchs T., Meinert A., Aberer W., et al. Benzalkonium chloride—a relevant contact allergen or irritant? Results of a multicenter study of the German Contact Allergy Group. Hautarzt. 1993;44:699–702. [PubMed] [Google Scholar]
- 148.Aki H. Interaction of antiseptic compounds with intercellular lipids of stratum corneum. J Therm Anal Calorimetry. 2002;68:553–560. [Google Scholar]
- 149.Kushla G.P., Zatz J.L. Correlation of water and lidocaine flux enhancement by cationic surfactants in vitro. J Pharm Sci. 1991;80:1079–1083. doi: 10.1002/jps.2600801117. [DOI] [PubMed] [Google Scholar]
- 150.Opinion of the Scientific Committee on Cosmetic Products and Non-Food Products Intended for Consumers Concerning Benzethonium Chloride. European Commission; 2002. [Google Scholar]
- 151.Buist H.E., van de Sandt J.J., van Burgsteden J.A., et al. Effects of single and repeated exposure to biocidal active substances on the barrier function of the skin in vitro. Regul Toxicol Pharmacol. 2005;43:76–84. doi: 10.1016/j.yrtph.2005.06.006. [DOI] [PubMed] [Google Scholar]
- 152.Lester W., Jr., Kaye S., Robertson O.H., et al. Factors of importance in the use of triethylene glycol vapor for aerial disinfection. Am J Public Health Nations Health. 1950;40:813–820. doi: 10.2105/ajph.40.7.813. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 153.Bartels M.J., McNett D.A., Timchalk C., et al. Comparative metabolism of ortho-phenylphenol in mouse, rat and man. Xenobiotica. 1998;28:579–594. doi: 10.1080/004982598239335. [DOI] [PubMed] [Google Scholar]
- 154.Cnubben N.H.P., Elliott G.R., Hakkert B.C., et al. Comparative in vitro–in vivo percutaneous penetration of the fungicide ortho-phenylphenol. Regul Toxicol Pharmacol. 2002;35:198–208. doi: 10.1006/rtph.2001.1530. [DOI] [PubMed] [Google Scholar]
- 155.Selim S. Pharma Bio-Research Clinics Bv; Assen, The Netherlands: 1996. A Single Dose Open Label Study to Investigate the Absorption and Excretion of 14c/13c-Labeled Orthophenylphenol Formulation After Dermal Application to Healthy Volunteers. [Google Scholar]
- 156.Timchalk C., Selim S., Sangha G., et al. The pharmacokinetics and metabolism of 14C/13C-labeled ortho-phenylphenol formation following dermal application to human volunteers. Hum Exp Toxicol. 1998;17:411–417. doi: 10.1177/096032719801700801. [DOI] [PubMed] [Google Scholar]